SlideShare ist ein Scribd-Unternehmen logo
1 von 31
Downloaden Sie, um offline zu lesen
[object Object]
Introduction ,[object Object]
OSTEOPOROSIS ,[object Object]
Age-related loss of trabecular bone
[object Object],[object Object]
Functions of the Vitamin D Endocrine System
Introduction ,[object Object],[object Object],[object Object]
Schematic diagram of the human vitamin D receptor gene
Aim of Work ,[object Object]
PATIENTS AND METHODS ,[object Object],[object Object]
Identification of Vit. D receptor [FOKI, BSMI] polymorphism by PCR technique followed by RFLP analysis ,[object Object],[object Object],[object Object]
DNA Amplification with the Polymerase Chain Reaction (PCR) Make copies ( extend primers ) Starting DNA Template 5’ 5’ 3’ 3’ 5’ 5’ 3’ 3’ Add primers ( anneal ) 5’ 3’ 3’ 5’ Forward primer Reverse primer Separate strands ( denature ) 5’ 5’ 3’ 3’
In 35 cycles at 100% efficiency, 1.07 billion copies of targeted DNA region are created PCR Copies DNA through Multiple Thermal Cycles Original DNA target region Thermal cycle Thermal cycle Thermal cycle
Mutation detection by restriction analysis 7  6  5  4  3  2  1  Ladder   69 bp-- 196 bp-- 265 bp--
7  6  5  4  3  2  1  Ladder 69 bp-- 196 bp-- 265 bp--
8  7  6  5  4  3  2  1  Ladder   200 bp 650 bp  850 bp
RESULTS
Body mass index of osteoporotic and controls
Distribution of different genotypes of FOKI polymorphism & alleles frequency in patients & controls:   FF genotype Ff genotype ff  genotype Allele (%) F  f Patients (n=50) N (%) 34 (68) 9 (18) 7 (14) 72.9  27.1 Controls (n=20) N (%) 20 (100) 0 (0) 0 (0) 100 0
Distribution of different genotypes of BSMI polymorphism & alleles frequency in patients & controls:   BB genotype Bb genotype bb  genotype Allele (%) B  b Patients (n=50) N (%) 27 (54) 15 (30) 8 (16) 64.6  35.4 Controls (n=20) N (%) 1 (5) 2 (10) 17 (85) 13.6 86.4
Comparison of the studied parameters in FOKI   0.07 0.68±.088 .74 ± .140 BMD lumbar (g/cm 2 ) 0.000 0.68±.040 0.77 ± .129 BMD femoral (g/cm 2 ) 0.04 -2.11 ±0 .91 -1.54 ±  1.14 T score lumbar 0.3 -1.21 ± 1.14 -.94  ±  .983 T scorefemoral P-value Ff+ff (N=16) Mean ± SD FF (N=54) Mean ± SD Variables
BMD lumbar of osteoporotic patients
Comparison of the studied parameters in BSMI 0.000 0.67±0.10 0.84 ± 0.11 BMD lumbar (g/cm 2 ) 0.000 0.70 ±0 .07 0.85  ±0 .13 BMD femoral (g/cm 2 ) 0.001 -2.00 ± 1.02 -1.08 ±  1.05 T score lumbar 0.10 -1.14 ± 1.06 -0.75  ± 0 .92 T scorefemoral P-value Bb+bb (N=45) Mean ± SD bb (N=25) Mean ± SD Variables
BMD lumbar of osteoporotic patients
Combined genotypes of BSMI and FOKI  of osteoporotic patients
Combined genotype of BSMI and FOKI of controls
O.R ratio of FOK1genotypes of patients and controls:     (32) (0) (%)   16 0 Count Ff+ff   (68) (100) (%)   1.588(1.29-1.95)  0.004 34 20 Count FF   cases control FOK1   OR (95% CI) P value GROUP
O.R ratio of BSM1 genotypes of patients and controls: (16) (85) (%) 8 17 Count bb (84) (15) (% ) 29.75(7.04-125.8)  0.000 42 3 Count BB+Bb cases control BSM1
Conclusion  ,[object Object]
[object Object]
Thank you

Weitere ähnliche Inhalte

Andere mochten auch (18)

Common reproductive health conditions
Common reproductive health conditionsCommon reproductive health conditions
Common reproductive health conditions
 
184 toll like receptor 4 and atherosclerosis
184 toll like receptor 4 and atherosclerosis184 toll like receptor 4 and atherosclerosis
184 toll like receptor 4 and atherosclerosis
 
Pathways07 tlr
Pathways07 tlrPathways07 tlr
Pathways07 tlr
 
Immunisatie1
Immunisatie1Immunisatie1
Immunisatie1
 
The Effects Of Soy Isoflavone On Bone Mineral Density In Pre And Postmenopau...
The Effects Of Soy Isoflavone On Bone Mineral Density In Pre  And Postmenopau...The Effects Of Soy Isoflavone On Bone Mineral Density In Pre  And Postmenopau...
The Effects Of Soy Isoflavone On Bone Mineral Density In Pre And Postmenopau...
 
Receptores tipo toll y obesidad
Receptores tipo toll y obesidadReceptores tipo toll y obesidad
Receptores tipo toll y obesidad
 
TLR - Kashmeera
TLR - KashmeeraTLR - Kashmeera
TLR - Kashmeera
 
Toll-like Receptors in Inflammation: Host Defense Webinar Series Part 2
Toll-like Receptors in Inflammation: Host Defense Webinar Series Part 2Toll-like Receptors in Inflammation: Host Defense Webinar Series Part 2
Toll-like Receptors in Inflammation: Host Defense Webinar Series Part 2
 
TLR -Toll Like Receptors
TLR -Toll Like ReceptorsTLR -Toll Like Receptors
TLR -Toll Like Receptors
 
Pathogen recognition
Pathogen recognitionPathogen recognition
Pathogen recognition
 
Toll like receptors
Toll like receptorsToll like receptors
Toll like receptors
 
Postmenopausal osteoporosis
Postmenopausal osteoporosis Postmenopausal osteoporosis
Postmenopausal osteoporosis
 
TLR
TLRTLR
TLR
 
Toll like receptors
Toll like receptors   Toll like receptors
Toll like receptors
 
Innate Immunity
Innate ImmunityInnate Immunity
Innate Immunity
 
Innate immunity
Innate immunityInnate immunity
Innate immunity
 
polymorphism
polymorphism polymorphism
polymorphism
 
Genetic polymorphism
Genetic polymorphismGenetic polymorphism
Genetic polymorphism
 

Ähnlich wie Pattern of vitamin d receptor polymorphism

Association Study of Single Nucleotide Polymorphism of PTH Gene in Osteopor...
Association Study of Single  Nucleotide Polymorphism of PTH  Gene in Osteopor...Association Study of Single  Nucleotide Polymorphism of PTH  Gene in Osteopor...
Association Study of Single Nucleotide Polymorphism of PTH Gene in Osteopor...Alia Iqniebi
 
Integrating TBS Into Your Clinical Practice.pdf
Integrating TBS Into Your Clinical Practice.pdfIntegrating TBS Into Your Clinical Practice.pdf
Integrating TBS Into Your Clinical Practice.pdfssuser4eaa71
 
Hormonal Causes of Secondary Osteoporosis
Hormonal Causes of Secondary OsteoporosisHormonal Causes of Secondary Osteoporosis
Hormonal Causes of Secondary OsteoporosisIris Thiele Isip-Tan
 
Lunch session p lakatos
Lunch session p lakatosLunch session p lakatos
Lunch session p lakatosAsszisztencia
 
Way+forward+in+osteoporosis%3aa+disease+which+is+no+longer+silent
Way+forward+in+osteoporosis%3aa+disease+which+is+no+longer+silentWay+forward+in+osteoporosis%3aa+disease+which+is+no+longer+silent
Way+forward+in+osteoporosis%3aa+disease+which+is+no+longer+silentdhavalshah4424
 
Multiple Myeloma.pptx
Multiple Myeloma.pptxMultiple Myeloma.pptx
Multiple Myeloma.pptxkezias7
 
Prevalence of osteoporosis in 100 iraqi patients with systemic
Prevalence of osteoporosis in 100 iraqi patients with systemicPrevalence of osteoporosis in 100 iraqi patients with systemic
Prevalence of osteoporosis in 100 iraqi patients with systemicAlexander Decker
 
Osteoporosis 2016 | Diabetes and bone: Prof. Serge Ferrari #osteo2016
Osteoporosis 2016 | Diabetes and bone: Prof. Serge Ferrari #osteo2016Osteoporosis 2016 | Diabetes and bone: Prof. Serge Ferrari #osteo2016
Osteoporosis 2016 | Diabetes and bone: Prof. Serge Ferrari #osteo2016National Osteoporosis Society
 
Vitamin D and Bone Health
Vitamin D and Bone HealthVitamin D and Bone Health
Vitamin D and Bone Healthdemiss
 
Osteoporosis 2016 | DXA and beyond: Dr Nicola Crabtree #osteo2016
Osteoporosis 2016 | DXA and beyond: Dr Nicola Crabtree #osteo2016Osteoporosis 2016 | DXA and beyond: Dr Nicola Crabtree #osteo2016
Osteoporosis 2016 | DXA and beyond: Dr Nicola Crabtree #osteo2016National Osteoporosis Society
 
Osteoporosis, Diagnosis and treatment
Osteoporosis, Diagnosis and treatmentOsteoporosis, Diagnosis and treatment
Osteoporosis, Diagnosis and treatmentStalin Chowdary
 
Osteoporosis%203rd%20yr[1]
Osteoporosis%203rd%20yr[1]Osteoporosis%203rd%20yr[1]
Osteoporosis%203rd%20yr[1]cotitoblue
 
Vitamin D and Multiple Sclerosis
Vitamin D and Multiple SclerosisVitamin D and Multiple Sclerosis
Vitamin D and Multiple SclerosisMS Trust
 
Management of osteoporosis
Management of osteoporosisManagement of osteoporosis
Management of osteoporosisAshok Bhatt
 

Ähnlich wie Pattern of vitamin d receptor polymorphism (20)

Association Study of Single Nucleotide Polymorphism of PTH Gene in Osteopor...
Association Study of Single  Nucleotide Polymorphism of PTH  Gene in Osteopor...Association Study of Single  Nucleotide Polymorphism of PTH  Gene in Osteopor...
Association Study of Single Nucleotide Polymorphism of PTH Gene in Osteopor...
 
Integrating TBS Into Your Clinical Practice.pdf
Integrating TBS Into Your Clinical Practice.pdfIntegrating TBS Into Your Clinical Practice.pdf
Integrating TBS Into Your Clinical Practice.pdf
 
Hormonal Causes of Secondary Osteoporosis
Hormonal Causes of Secondary OsteoporosisHormonal Causes of Secondary Osteoporosis
Hormonal Causes of Secondary Osteoporosis
 
Lunch session p lakatos
Lunch session p lakatosLunch session p lakatos
Lunch session p lakatos
 
Way+forward+in+osteoporosis%3aa+disease+which+is+no+longer+silent
Way+forward+in+osteoporosis%3aa+disease+which+is+no+longer+silentWay+forward+in+osteoporosis%3aa+disease+which+is+no+longer+silent
Way+forward+in+osteoporosis%3aa+disease+which+is+no+longer+silent
 
Multiple Myeloma.pptx
Multiple Myeloma.pptxMultiple Myeloma.pptx
Multiple Myeloma.pptx
 
Prevalence of osteoporosis in 100 iraqi patients with systemic
Prevalence of osteoporosis in 100 iraqi patients with systemicPrevalence of osteoporosis in 100 iraqi patients with systemic
Prevalence of osteoporosis in 100 iraqi patients with systemic
 
Osteoporosis 2016 | Diabetes and bone: Prof. Serge Ferrari #osteo2016
Osteoporosis 2016 | Diabetes and bone: Prof. Serge Ferrari #osteo2016Osteoporosis 2016 | Diabetes and bone: Prof. Serge Ferrari #osteo2016
Osteoporosis 2016 | Diabetes and bone: Prof. Serge Ferrari #osteo2016
 
Vitamin D and Bone Health
Vitamin D and Bone HealthVitamin D and Bone Health
Vitamin D and Bone Health
 
ECCLU 2011 - N. Clarke - Bone targeted agents
ECCLU 2011 - N. Clarke - Bone targeted agentsECCLU 2011 - N. Clarke - Bone targeted agents
ECCLU 2011 - N. Clarke - Bone targeted agents
 
Osteoporosis
OsteoporosisOsteoporosis
Osteoporosis
 
Ruth Loos-Lo último en obesidad
Ruth Loos-Lo último en obesidadRuth Loos-Lo último en obesidad
Ruth Loos-Lo último en obesidad
 
Osteoporosis 2016 | DXA and beyond: Dr Nicola Crabtree #osteo2016
Osteoporosis 2016 | DXA and beyond: Dr Nicola Crabtree #osteo2016Osteoporosis 2016 | DXA and beyond: Dr Nicola Crabtree #osteo2016
Osteoporosis 2016 | DXA and beyond: Dr Nicola Crabtree #osteo2016
 
Osteoporosis, Diagnosis and treatment
Osteoporosis, Diagnosis and treatmentOsteoporosis, Diagnosis and treatment
Osteoporosis, Diagnosis and treatment
 
Seminar 22-11-2014 Prof. Dr. W.F. Lems - Highlights ASBMR
Seminar 22-11-2014 Prof. Dr. W.F. Lems - Highlights ASBMRSeminar 22-11-2014 Prof. Dr. W.F. Lems - Highlights ASBMR
Seminar 22-11-2014 Prof. Dr. W.F. Lems - Highlights ASBMR
 
Osteoporosis%203rd%20yr[1]
Osteoporosis%203rd%20yr[1]Osteoporosis%203rd%20yr[1]
Osteoporosis%203rd%20yr[1]
 
IWO bijeenkomst - 14 november - Dr. F. Malgo
IWO bijeenkomst - 14 november - Dr. F. MalgoIWO bijeenkomst - 14 november - Dr. F. Malgo
IWO bijeenkomst - 14 november - Dr. F. Malgo
 
Vitamin D and Multiple Sclerosis
Vitamin D and Multiple SclerosisVitamin D and Multiple Sclerosis
Vitamin D and Multiple Sclerosis
 
Management of osteoporosis
Management of osteoporosisManagement of osteoporosis
Management of osteoporosis
 
Seminar 28-11-2015 Prof. Dr. W.F. Lems
Seminar 28-11-2015 Prof. Dr. W.F. LemsSeminar 28-11-2015 Prof. Dr. W.F. Lems
Seminar 28-11-2015 Prof. Dr. W.F. Lems
 

Mehr von Hesham Gaber

Management of poor ovarian response
Management of poor ovarian responseManagement of poor ovarian response
Management of poor ovarian responseHesham Gaber
 
So much evidence 1
So much evidence 1So much evidence 1
So much evidence 1Hesham Gaber
 
So much evidence 1
So much evidence 1So much evidence 1
So much evidence 1Hesham Gaber
 
Management of poor ovarian response
Management of poor ovarian responseManagement of poor ovarian response
Management of poor ovarian responseHesham Gaber
 
Thromboprophylaxis
ThromboprophylaxisThromboprophylaxis
ThromboprophylaxisHesham Gaber
 
Why to know statistics
Why to know statisticsWhy to know statistics
Why to know statisticsHesham Gaber
 
Statistics & infertility
Statistics & infertilityStatistics & infertility
Statistics & infertilityHesham Gaber
 
Research methodology 101
Research methodology 101Research methodology 101
Research methodology 101Hesham Gaber
 
Randomised controlled trials
Randomised controlled trialsRandomised controlled trials
Randomised controlled trialsHesham Gaber
 
Ovarian hyperstimulation syndrome
Ovarian hyperstimulation syndromeOvarian hyperstimulation syndrome
Ovarian hyperstimulation syndromeHesham Gaber
 

Mehr von Hesham Gaber (20)

Management of poor ovarian response
Management of poor ovarian responseManagement of poor ovarian response
Management of poor ovarian response
 
High responders
High respondersHigh responders
High responders
 
Prognostic models
Prognostic modelsPrognostic models
Prognostic models
 
GnRH antagonists
GnRH antagonistsGnRH antagonists
GnRH antagonists
 
Poor
PoorPoor
Poor
 
Infertility
InfertilityInfertility
Infertility
 
So much evidence 1
So much evidence 1So much evidence 1
So much evidence 1
 
So much evidence 1
So much evidence 1So much evidence 1
So much evidence 1
 
Contraception
ContraceptionContraception
Contraception
 
Management of poor ovarian response
Management of poor ovarian responseManagement of poor ovarian response
Management of poor ovarian response
 
Thromboprophylaxis
ThromboprophylaxisThromboprophylaxis
Thromboprophylaxis
 
So much evidence
So much evidenceSo much evidence
So much evidence
 
Why to know statistics
Why to know statisticsWhy to know statistics
Why to know statistics
 
Uterine sarcoma
Uterine sarcomaUterine sarcoma
Uterine sarcoma
 
Systematic review
Systematic reviewSystematic review
Systematic review
 
Statistics & infertility
Statistics & infertilityStatistics & infertility
Statistics & infertility
 
Research methodology 101
Research methodology 101Research methodology 101
Research methodology 101
 
Randomised controlled trials
Randomised controlled trialsRandomised controlled trials
Randomised controlled trials
 
Paternal age
Paternal agePaternal age
Paternal age
 
Ovarian hyperstimulation syndrome
Ovarian hyperstimulation syndromeOvarian hyperstimulation syndrome
Ovarian hyperstimulation syndrome
 

Kürzlich hochgeladen

Potential of AI (Generative AI) in Business: Learnings and Insights
Potential of AI (Generative AI) in Business: Learnings and InsightsPotential of AI (Generative AI) in Business: Learnings and Insights
Potential of AI (Generative AI) in Business: Learnings and InsightsRavi Sanghani
 
UiPath Community: Communication Mining from Zero to Hero
UiPath Community: Communication Mining from Zero to HeroUiPath Community: Communication Mining from Zero to Hero
UiPath Community: Communication Mining from Zero to HeroUiPathCommunity
 
Digital Identity is Under Attack: FIDO Paris Seminar.pptx
Digital Identity is Under Attack: FIDO Paris Seminar.pptxDigital Identity is Under Attack: FIDO Paris Seminar.pptx
Digital Identity is Under Attack: FIDO Paris Seminar.pptxLoriGlavin3
 
Scale your database traffic with Read & Write split using MySQL Router
Scale your database traffic with Read & Write split using MySQL RouterScale your database traffic with Read & Write split using MySQL Router
Scale your database traffic with Read & Write split using MySQL RouterMydbops
 
[Webinar] SpiraTest - Setting New Standards in Quality Assurance
[Webinar] SpiraTest - Setting New Standards in Quality Assurance[Webinar] SpiraTest - Setting New Standards in Quality Assurance
[Webinar] SpiraTest - Setting New Standards in Quality AssuranceInflectra
 
Arizona Broadband Policy Past, Present, and Future Presentation 3/25/24
Arizona Broadband Policy Past, Present, and Future Presentation 3/25/24Arizona Broadband Policy Past, Present, and Future Presentation 3/25/24
Arizona Broadband Policy Past, Present, and Future Presentation 3/25/24Mark Goldstein
 
Decarbonising Buildings: Making a net-zero built environment a reality
Decarbonising Buildings: Making a net-zero built environment a realityDecarbonising Buildings: Making a net-zero built environment a reality
Decarbonising Buildings: Making a net-zero built environment a realityIES VE
 
Genislab builds better products and faster go-to-market with Lean project man...
Genislab builds better products and faster go-to-market with Lean project man...Genislab builds better products and faster go-to-market with Lean project man...
Genislab builds better products and faster go-to-market with Lean project man...Farhan Tariq
 
React Native vs Ionic - The Best Mobile App Framework
React Native vs Ionic - The Best Mobile App FrameworkReact Native vs Ionic - The Best Mobile App Framework
React Native vs Ionic - The Best Mobile App FrameworkPixlogix Infotech
 
Generative AI - Gitex v1Generative AI - Gitex v1.pptx
Generative AI - Gitex v1Generative AI - Gitex v1.pptxGenerative AI - Gitex v1Generative AI - Gitex v1.pptx
Generative AI - Gitex v1Generative AI - Gitex v1.pptxfnnc6jmgwh
 
TeamStation AI System Report LATAM IT Salaries 2024
TeamStation AI System Report LATAM IT Salaries 2024TeamStation AI System Report LATAM IT Salaries 2024
TeamStation AI System Report LATAM IT Salaries 2024Lonnie McRorey
 
The Future Roadmap for the Composable Data Stack - Wes McKinney - Data Counci...
The Future Roadmap for the Composable Data Stack - Wes McKinney - Data Counci...The Future Roadmap for the Composable Data Stack - Wes McKinney - Data Counci...
The Future Roadmap for the Composable Data Stack - Wes McKinney - Data Counci...Wes McKinney
 
Data governance with Unity Catalog Presentation
Data governance with Unity Catalog PresentationData governance with Unity Catalog Presentation
Data governance with Unity Catalog PresentationKnoldus Inc.
 
Long journey of Ruby standard library at RubyConf AU 2024
Long journey of Ruby standard library at RubyConf AU 2024Long journey of Ruby standard library at RubyConf AU 2024
Long journey of Ruby standard library at RubyConf AU 2024Hiroshi SHIBATA
 
Passkey Providers and Enabling Portability: FIDO Paris Seminar.pptx
Passkey Providers and Enabling Portability: FIDO Paris Seminar.pptxPasskey Providers and Enabling Portability: FIDO Paris Seminar.pptx
Passkey Providers and Enabling Portability: FIDO Paris Seminar.pptxLoriGlavin3
 
The Ultimate Guide to Choosing WordPress Pros and Cons
The Ultimate Guide to Choosing WordPress Pros and ConsThe Ultimate Guide to Choosing WordPress Pros and Cons
The Ultimate Guide to Choosing WordPress Pros and ConsPixlogix Infotech
 
How to Effectively Monitor SD-WAN and SASE Environments with ThousandEyes
How to Effectively Monitor SD-WAN and SASE Environments with ThousandEyesHow to Effectively Monitor SD-WAN and SASE Environments with ThousandEyes
How to Effectively Monitor SD-WAN and SASE Environments with ThousandEyesThousandEyes
 
Microsoft 365 Copilot: How to boost your productivity with AI – Part one: Ado...
Microsoft 365 Copilot: How to boost your productivity with AI – Part one: Ado...Microsoft 365 Copilot: How to boost your productivity with AI – Part one: Ado...
Microsoft 365 Copilot: How to boost your productivity with AI – Part one: Ado...Nikki Chapple
 
TrustArc Webinar - How to Build Consumer Trust Through Data Privacy
TrustArc Webinar - How to Build Consumer Trust Through Data PrivacyTrustArc Webinar - How to Build Consumer Trust Through Data Privacy
TrustArc Webinar - How to Build Consumer Trust Through Data PrivacyTrustArc
 
Connecting the Dots for Information Discovery.pdf
Connecting the Dots for Information Discovery.pdfConnecting the Dots for Information Discovery.pdf
Connecting the Dots for Information Discovery.pdfNeo4j
 

Kürzlich hochgeladen (20)

Potential of AI (Generative AI) in Business: Learnings and Insights
Potential of AI (Generative AI) in Business: Learnings and InsightsPotential of AI (Generative AI) in Business: Learnings and Insights
Potential of AI (Generative AI) in Business: Learnings and Insights
 
UiPath Community: Communication Mining from Zero to Hero
UiPath Community: Communication Mining from Zero to HeroUiPath Community: Communication Mining from Zero to Hero
UiPath Community: Communication Mining from Zero to Hero
 
Digital Identity is Under Attack: FIDO Paris Seminar.pptx
Digital Identity is Under Attack: FIDO Paris Seminar.pptxDigital Identity is Under Attack: FIDO Paris Seminar.pptx
Digital Identity is Under Attack: FIDO Paris Seminar.pptx
 
Scale your database traffic with Read & Write split using MySQL Router
Scale your database traffic with Read & Write split using MySQL RouterScale your database traffic with Read & Write split using MySQL Router
Scale your database traffic with Read & Write split using MySQL Router
 
[Webinar] SpiraTest - Setting New Standards in Quality Assurance
[Webinar] SpiraTest - Setting New Standards in Quality Assurance[Webinar] SpiraTest - Setting New Standards in Quality Assurance
[Webinar] SpiraTest - Setting New Standards in Quality Assurance
 
Arizona Broadband Policy Past, Present, and Future Presentation 3/25/24
Arizona Broadband Policy Past, Present, and Future Presentation 3/25/24Arizona Broadband Policy Past, Present, and Future Presentation 3/25/24
Arizona Broadband Policy Past, Present, and Future Presentation 3/25/24
 
Decarbonising Buildings: Making a net-zero built environment a reality
Decarbonising Buildings: Making a net-zero built environment a realityDecarbonising Buildings: Making a net-zero built environment a reality
Decarbonising Buildings: Making a net-zero built environment a reality
 
Genislab builds better products and faster go-to-market with Lean project man...
Genislab builds better products and faster go-to-market with Lean project man...Genislab builds better products and faster go-to-market with Lean project man...
Genislab builds better products and faster go-to-market with Lean project man...
 
React Native vs Ionic - The Best Mobile App Framework
React Native vs Ionic - The Best Mobile App FrameworkReact Native vs Ionic - The Best Mobile App Framework
React Native vs Ionic - The Best Mobile App Framework
 
Generative AI - Gitex v1Generative AI - Gitex v1.pptx
Generative AI - Gitex v1Generative AI - Gitex v1.pptxGenerative AI - Gitex v1Generative AI - Gitex v1.pptx
Generative AI - Gitex v1Generative AI - Gitex v1.pptx
 
TeamStation AI System Report LATAM IT Salaries 2024
TeamStation AI System Report LATAM IT Salaries 2024TeamStation AI System Report LATAM IT Salaries 2024
TeamStation AI System Report LATAM IT Salaries 2024
 
The Future Roadmap for the Composable Data Stack - Wes McKinney - Data Counci...
The Future Roadmap for the Composable Data Stack - Wes McKinney - Data Counci...The Future Roadmap for the Composable Data Stack - Wes McKinney - Data Counci...
The Future Roadmap for the Composable Data Stack - Wes McKinney - Data Counci...
 
Data governance with Unity Catalog Presentation
Data governance with Unity Catalog PresentationData governance with Unity Catalog Presentation
Data governance with Unity Catalog Presentation
 
Long journey of Ruby standard library at RubyConf AU 2024
Long journey of Ruby standard library at RubyConf AU 2024Long journey of Ruby standard library at RubyConf AU 2024
Long journey of Ruby standard library at RubyConf AU 2024
 
Passkey Providers and Enabling Portability: FIDO Paris Seminar.pptx
Passkey Providers and Enabling Portability: FIDO Paris Seminar.pptxPasskey Providers and Enabling Portability: FIDO Paris Seminar.pptx
Passkey Providers and Enabling Portability: FIDO Paris Seminar.pptx
 
The Ultimate Guide to Choosing WordPress Pros and Cons
The Ultimate Guide to Choosing WordPress Pros and ConsThe Ultimate Guide to Choosing WordPress Pros and Cons
The Ultimate Guide to Choosing WordPress Pros and Cons
 
How to Effectively Monitor SD-WAN and SASE Environments with ThousandEyes
How to Effectively Monitor SD-WAN and SASE Environments with ThousandEyesHow to Effectively Monitor SD-WAN and SASE Environments with ThousandEyes
How to Effectively Monitor SD-WAN and SASE Environments with ThousandEyes
 
Microsoft 365 Copilot: How to boost your productivity with AI – Part one: Ado...
Microsoft 365 Copilot: How to boost your productivity with AI – Part one: Ado...Microsoft 365 Copilot: How to boost your productivity with AI – Part one: Ado...
Microsoft 365 Copilot: How to boost your productivity with AI – Part one: Ado...
 
TrustArc Webinar - How to Build Consumer Trust Through Data Privacy
TrustArc Webinar - How to Build Consumer Trust Through Data PrivacyTrustArc Webinar - How to Build Consumer Trust Through Data Privacy
TrustArc Webinar - How to Build Consumer Trust Through Data Privacy
 
Connecting the Dots for Information Discovery.pdf
Connecting the Dots for Information Discovery.pdfConnecting the Dots for Information Discovery.pdf
Connecting the Dots for Information Discovery.pdf
 

Pattern of vitamin d receptor polymorphism

  • 1.
  • 2.
  • 3.
  • 4. Age-related loss of trabecular bone
  • 5.
  • 6. Functions of the Vitamin D Endocrine System
  • 7.
  • 8. Schematic diagram of the human vitamin D receptor gene
  • 9.
  • 10.
  • 11.
  • 12. DNA Amplification with the Polymerase Chain Reaction (PCR) Make copies ( extend primers ) Starting DNA Template 5’ 5’ 3’ 3’ 5’ 5’ 3’ 3’ Add primers ( anneal ) 5’ 3’ 3’ 5’ Forward primer Reverse primer Separate strands ( denature ) 5’ 5’ 3’ 3’
  • 13. In 35 cycles at 100% efficiency, 1.07 billion copies of targeted DNA region are created PCR Copies DNA through Multiple Thermal Cycles Original DNA target region Thermal cycle Thermal cycle Thermal cycle
  • 14. Mutation detection by restriction analysis 7 6 5 4 3 2 1 Ladder 69 bp-- 196 bp-- 265 bp--
  • 15. 7 6 5 4 3 2 1 Ladder 69 bp-- 196 bp-- 265 bp--
  • 16. 8 7 6 5 4 3 2 1 Ladder 200 bp 650 bp 850 bp
  • 18. Body mass index of osteoporotic and controls
  • 19. Distribution of different genotypes of FOKI polymorphism & alleles frequency in patients & controls: FF genotype Ff genotype ff genotype Allele (%) F f Patients (n=50) N (%) 34 (68) 9 (18) 7 (14) 72.9 27.1 Controls (n=20) N (%) 20 (100) 0 (0) 0 (0) 100 0
  • 20. Distribution of different genotypes of BSMI polymorphism & alleles frequency in patients & controls: BB genotype Bb genotype bb genotype Allele (%) B b Patients (n=50) N (%) 27 (54) 15 (30) 8 (16) 64.6 35.4 Controls (n=20) N (%) 1 (5) 2 (10) 17 (85) 13.6 86.4
  • 21. Comparison of the studied parameters in FOKI 0.07 0.68±.088 .74 ± .140 BMD lumbar (g/cm 2 ) 0.000 0.68±.040 0.77 ± .129 BMD femoral (g/cm 2 ) 0.04 -2.11 ±0 .91 -1.54 ± 1.14 T score lumbar 0.3 -1.21 ± 1.14 -.94 ± .983 T scorefemoral P-value Ff+ff (N=16) Mean ± SD FF (N=54) Mean ± SD Variables
  • 22. BMD lumbar of osteoporotic patients
  • 23. Comparison of the studied parameters in BSMI 0.000 0.67±0.10 0.84 ± 0.11 BMD lumbar (g/cm 2 ) 0.000 0.70 ±0 .07 0.85 ±0 .13 BMD femoral (g/cm 2 ) 0.001 -2.00 ± 1.02 -1.08 ± 1.05 T score lumbar 0.10 -1.14 ± 1.06 -0.75 ± 0 .92 T scorefemoral P-value Bb+bb (N=45) Mean ± SD bb (N=25) Mean ± SD Variables
  • 24. BMD lumbar of osteoporotic patients
  • 25. Combined genotypes of BSMI and FOKI of osteoporotic patients
  • 26. Combined genotype of BSMI and FOKI of controls
  • 27. O.R ratio of FOK1genotypes of patients and controls:   (32) (0) (%)   16 0 Count Ff+ff   (68) (100) (%)   1.588(1.29-1.95) 0.004 34 20 Count FF   cases control FOK1   OR (95% CI) P value GROUP
  • 28. O.R ratio of BSM1 genotypes of patients and controls: (16) (85) (%) 8 17 Count bb (84) (15) (% ) 29.75(7.04-125.8) 0.000 42 3 Count BB+Bb cases control BSM1
  • 29.
  • 30.

Hinweis der Redaktion

  1. extraction of DNA using salting out technique followed by amplification of extracted DNA at exon 2 for FOKI & intron 8 for BSMI and amplified DNA was then cut by restriction enzyme FOKI for detection of FOKI polymorphism and by enzyme BSMI for detection of BSMI polymorphism and then electrophoresis of the DNA was done on agarose gel.